Immunological monitoring in critically ill associated immune dysfunction

doi:10.3877/cma.j.issn.2096-1537.2019.01.011

Abstract

Abstract:

In recent years, critically ill associated immune dysfunction has been drawn a considerable attention in intensive care unit. Monitoring immunological function in critical illness includes innate and acquired immune function may help to determine the nature and degree of immune change, evaluate immune function status, assess the severity of disease, personalize the immunomodulatory therapy, evaluate the effect of immunotherapy, and predict the prognosis of critically ill patients. Therefore, precision of immune function monitoring has important clinical meaning in the critically ill patients. This review focuses on the recent findings in monitoring critically ill associated immune dysfunction.

Key words: Critically ill associated immune dysfunction, Immunological monitoring, Innate immunity, Adaptive immunity, Cellular immunity, Humoral immunity

Jun Liu. Immunological monitoring in critically ill associated immune dysfunction[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2019, 05(01): 56-63.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-1537.2019.01.011

https://icu.cma-cmc.com.cn/EN/Y2019/V05/I01/56

References 47

1	Azoulay E, Soares M, Benoit D. Focus on immunocompromised patients [J]. Intensive Care Med, 2016, 42(3): 463-465.
2	Bermejo-Martin JF, Andaluz-Ojeda D, Almansa R, et al. Defining immunological dysfunction in sepsis: A requisite tool for precision medicine [J]. J Infect, 2016, 72(5): 525-536.
3	Hall MW, Knatz NL, Vetterly C, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome [J]. Intensive Care Med, 2011, 37(3): 525-532.
4	Boomer JS, To K, Chang KC, Takasu O, et al. Immunosuppression in patients who die of sepsis and multiple organ failure [J]. JAMA, 2011, 306(23): 2594-2605.
5	Drewry AM, Hotchkiss RS. Sepsis: Revising definitions of sepsis [J]. Nat Rev Nephrol, 2015, 11(6): 326-328.
6	Iwasaki A, Medzhitov R. A new shield for a cytokine storm [J]. Cell, 2011, 146(6): 861-862.
7	Otto GP, Sossdorf M, Claus RA, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate [J]. Crit Care, 2011, 15(4): R183.
8	Cajander S, Bäckman A, Tina E, et al. Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach toidentify immunosuppression in sepsis [J]. Crit Care, 2013, 17(5): R223.
9	Wu JF, Ma J, Chen J, et al. Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor ofmortality in severe sepsis [J]. Crit Care, 2011, 15(5): R220.
10	Meisel C, Schefold JC, Pschowski R, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial [J]. Am J Respir Crit Care Med, 2009, 180(7): 640-648.
11	Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans [J]. J Exp Med, 2011, 208(13): 2581-2590.
12	Russell JA. Genomics and pharmacogenomics of sepsis: so close and yet so far [J]. Crit Care, 2016, 20(1): 185.
13	Calvano SE, Xiao W, Richards DR, et al. A network-based analysis of systemic inflammation in humans [J]. Nature, 2005, 437(7061): 1032-1037.
14	Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management [J]. BMJ, 2016, 353: i1585.
15	Yang HM, Yu Y, Chai JK, et al. Low HLA-DR expression on CD14＋ monocytes of burn victims with sepsis, and the effect of carbachol in vitro [J]. Burns, 2008, 34(8): 1158-1162.
16	Delano MJ, Ward PA. The immune system′s role in sepsis progression, resolution, and long-term outcome [J]. Immunol Rev, 2016, 274(1): 330-353.
17	Kirchhoff C, Biberthaler P, Mutschler WE, et al. Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a cohort study [J]. Crit Care, 2009,13(3): R88.
18	Takahashi K, Satoi S, Yanagimoto H, et al. Circulating dendritic cells and development of septic complications after pancreatectomy for pancreatic cancer [J]. Arch Surg, 2007, 142(12): 1151-1157.
19	D′Arpa N, Accardo-Palumbo A, Amato G, et al. Circulating dendritic cells following burn [J]. Burns, 2009, 35(4): 513-518.
20	Dopheide JF, Obst V, Doppler C, et al. Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease [J]. Thromb Haemost, 2012,108(6): 1198-1207.
21	Riccardi F, Della Porta MG, Rovati B, et al. Flow cytometric analysis of peripheral blood dendritic cells in patients with severe sepsis [J]. Cytometry B Clin Cytom, 2011, 80(1): 14-21.
22	Giamarellos-Bourboulis EJ, Tsaganos T, Spyridaki E, et al. Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis [J]. Crit Care, 2006, 10(6): R166.
23	Andaluz-Ojeda D, Iglesias V, Bobillo F, et al. Early natural killer cell counts in blood predict mortality in severe sepsis [J]. Crit Care, 2011,15(5): R243.
24	Gloor B, Stahel PF, Müller CA, et al. Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis [J]. Scand J Gastroenterol, 2003, 38(10): 1078-1082.
25	Ren J, Zhao Y, Yuan Y, et al. Complement depletion deteriorates clinical outcomes of severe abdominal sepsis: a conspiratorof infection and coagulopathy in crime? [J]. PLoS One, 2012, 7(10): e47095.
26	Manson J, Cole E, De′Ath HD, et al. Early changes within the lymphocyte population are associated with the development ofmultiple organ dysfunction syndrome in trauma patients [J]. Crit Care, 2016, 20(1): 176.
27	Drewry AM, Samra N, Skrupky LP, et al. Persistent lymphopenia after diagnosis of sepsis predicts mortality [J]. Shock, 2014, 42(5): 383-391.
28	Patenaude J, D’Elia M, Hamelin C, et al. Burn injury induces a change in T cell homeostasis affecting preferentially CD4＋ T cells [J]. J Leukoc Biol, 2005, 77(2): 141-150.
29	Inatsu A, Kogiso M, Jeschke MG, et al. Lack of Th17 cell generation in patients with severe burn injuries [J]. J Immunol, 2011, 187(5): 2155-2161.
30	Sakaguchi S, Vignali DA, Rudensky AY, et al. The plasticity and stability of regulatory T cells [J]. Nat Rev Immunol, 2013,13(6):461-467.
31	Brunialti MK, Santos MC, Rigato O, et al. Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis [J]. PLoS One, 2012, 7(5): e37393.
32	Masopust D, Schenkel JM. The integration of T cell migration, differentiation and function [J]. Nat Rev Immunol, 2013, 13(5): 309-320.
33	O′Sullivan ST, Lederer JA, Horgan AF, et al. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection [J]. Ann Surg, 1995, 222(4): 482-490.
34	Spolarics Z, Siddiqi M, Siegel JH, et al. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients [J]. Crit Care Med, 2003, 31(6): 1722-1729.
35	Yu ZX, Ji MS, Yan J, et al. The ratio of Th17/Treg cells as a risk indicator in early acute respiratory distress syndrome [J]. Crit Care, 2015, 19: 82.
36	del Rosario Espinoza Mora M, Böhm M, Link A. The Th17/Treg imbalance in patients with cardiogenic shock [J]. Clin Res Cardiol, 2014, 103(4): 301-313.
37	Wang L, Song H, Gong Z, et al. Acute pulmonary embolism and dysfunction of CD3^＋ CD8^＋ T cell immunity [J]. Am J Respir Crit Care Med, 2011, 184(11): 1315.
38	Haoming S, Lemin W, Zhu G, et al. T cell-mediated immune deficiency or compromise in patients with CTEPH [J]. Am J Respir Crit Care Med, 2011, 183(3): 417-418.
39	Cui N, Wang H, Long Y, et al. CD8^＋ T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis [J]. Crit Care, 2013, 17(4): R157.
40	Gomez HG, Gonzalez SM, Londoño JM, et al. Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study [J]. Crit Care Med, 2014, 42(4): 771-780.
41	刘军, 吴允孚. 危重病相关免疫功能障碍 [J]. 中华急诊医学杂志, 2015, 24(8): 918-921.
42	Monserrat J, de Pablo R, Diaz-Martín D, et al. Early alterations of B cells in patients with septic shock [J]. Crit Care, 2013, 17(3): R105.
43	Andaluz-Ojeda D, Iglesias V, Bobillo F, et al. Early levels in blood of immunoglobulin M and natural killer cells predict outcome in nonseptic critically ill patients [J]. J Crit Care, 2013, 28(6): 1110.e7-1110.e10.
44	DiPiro JT, Howdieshell TR, Hamilton RG, et al. Immunoglobulin E and eosinophil counts are increased after sepsis in trauma patients [J]. Crit Care Med, 1998, 26(3): 465-469.
45	McLean AS, Tang B, Huang SJ. Investigating sepsis with biomarkers [J]. BMJ, 2015, 350: h254.
46	Sweeney TE, Shidham A, Wong HR, et al. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammationreveals a robust diagnostic gene set [J]. Sci Transl Med, 2015, 7(287): 287ra271.
47	张庆红, 姚咏明. 进一步重视创(烧)伤脓毒症的免疫监控 [J]. 中华急诊医学杂志, 2014, 23(2): 125-128.

[1]	Yanlan Zhang, Lin Xu, Caiying Wang, Lin Pang. Diagnostic value of lymphocyte subsets in children with severe influenza A [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2021, 15(06): 368-373.
[2]	Muqi Wang, Yaping Li, Dandan Feng, Huiling Deng, Yufeng Zhang, Wenjun Wang, Xiaoli Jia, Shuangsuo Dang. Expression and clinical significance of mitochondria antiviral signaling protein and mitochondria fusion protein of children with hand, foot and mouth disease [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2021, 15(01): 46-52.
[3]	Chunjing Du, Liuluan Zhu, Jingyuan Liu, Ang Li. New advances on the host immune response to Pneumocystis carinii [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2020, 14(06): 447-452.
[4]	Xiuxia Wu, Yuxia Chen, Qianqian Fan. Systematic review and clinical significance of immune function in neonates with infectious pneumonia [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2019, 13(02): 128-133.
[5]	Zhibin Yang, Enrui Shen, Li Pan, Lihui Zhao, Cong Wang, Yanxia Yang, Yang Li, Qiaofeng Wang, Shiwu Ma. Expression and clinical significance of serum interleukin-21 in patients with different types of tuberculosis [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2019, 13(01): 48-53.
[6]	Na Sun, Zhihai Chen. Hematological and immune system damage in patients of severe fever complicated with thrombocytopenia syndrome [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2018, 12(06): 538-542.
[7]	Yuan Ji, Bajin Wei. Review of research progress on the role of NLRP3 inflammasome in the pathogenesis of adverse reactions of organ transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 308-312.
[8]	Li Ren, Mingna Huang, Jiling Feng, Xihua Wu, Shiya Su. Study on the changes of cellular immunity and humoral immunity in patients with cerebral infarction [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2018, 08(06): 343-347.
[9]	Junjie Hu, Shao zhong Wei, Zhiguo Xiong, Bojun Yang. Effect of laparoscopic resection with natural orifice specimen extraction on short-term outcomes and cellular immunity for colorectal cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(04): 323-327.
[10]	Weiting Qin, Bingwei Sun. Further research and application of innate immunity [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2018, 04(04): 304-306.
[11]	Xiuli Tian, Zhijun Liu, Chunting Wang. Sepsis related immune mechanism [J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(08): 620-623.
[12]	Mingjing Wang, Yonggang Xu, Xiaoqing Ding, Richeng Quan, Haiyan Chen, Zhongyang Deng, Pan Zhao, Xiaomei Hu. Cellular immune function in patients with immune thrombocytopenia [J]. Chinese Journal of Clinicians(Electronic Edition), 2018, 12(02): 65-69.

Please choose a citation manager

Content to export